Lpl Financial LLC Amicus Therapeutics, Inc. Transaction History

Lpl Financial LLC

$320 Billion
Q3 2025

A detailed history of Lpl Financial LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 45,887 shares of FOLD stock, worth $435,008. This represents 0.0% of its overall portfolio holdings.

Number of Shares

45,887

Previous 24,417 87.93%

Holding current value

$435,008

Previous $139,000 159.71%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$5.84 - $8.57 $125,384 - $183,997	21,470 Added 87.93%	45,887 $361,000
Q2 2025 Aug 12, 2025	BUY	$5.64 - $8.0 $71,921 - $102,016	12,752 Added 109.32%	24,417 $139,000
Q1 2025 May 07, 2025	BUY	$8.16 - $9.85 $1,468 - $1,773	180 Added 1.57%	11,665 $95,000
Q4 2024 Feb 11, 2025	BUY	$9.36 - $12.01 $3,631 - $4,659	388 Added 3.5%	11,485 $108,000
Q3 2024 Nov 08, 2024	BUY	$9.55 - $12.09 $9,559 - $12,102	1,001 Added 9.91%	11,097 $118,000

Q2 2024 Aug 07, 2024	BUY	$9.04 - $11.75 $91,267 - $118,628	10,096 New	10,096 $100,000
Q1 2022 May 16, 2022	SELL	$7.89 - $12.48 $109,994 - $173,983	-13,941 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$9.82 - $12.44 $45,879 - $58,119	-4,672 Reduced 25.1%	13,941 $161,000
Q3 2021 Nov 15, 2021	BUY	$8.74 - $11.84 $162,677 - $220,377	18,613 New	18,613 $178,000
Q2 2021 Aug 13, 2021	SELL	$8.71 - $10.72 $113,534 - $139,735	-13,035 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$9.2 - $23.86 $28,685 - $74,395	3,118 Added 31.44%	13,035 $129,000
Q4 2020 Feb 12, 2021	SELL	$13.47 - $24.89 $314,093 - $580,385	-23,318 Reduced 70.16%	9,917 $229,000
Q3 2020 Nov 09, 2020	SELL	$12.89 - $15.89 $2,745 - $3,384	-213 Reduced 0.64%	33,235 $469,000
Q2 2020 Aug 13, 2020	BUY	$8.86 - $15.69 $29,415 - $52,090	3,320 Added 11.02%	33,448 $504,000
Q1 2020 May 14, 2020	BUY	$6.63 - $11.16 $132,367 - $222,809	19,965 Added 196.45%	30,128 $278,000
Q4 2019 Feb 14, 2020	SELL	$7.48 - $10.75 $13,628 - $19,586	-1,822 Reduced 15.2%	10,163 $99,000
Q3 2019 Nov 13, 2019	SELL	$8.02 - $13.25 $7,113 - $11,752	-887 Reduced 6.89%	11,985 $96,000
Q2 2019 Aug 09, 2019	SELL	$10.96 - $14.4 $16,067 - $21,110	-1,466 Reduced 10.22%	12,872 $161,000
Q1 2019 May 08, 2019	SELL	$10.04 - $13.92 $8,985 - $12,458	-895 Reduced 5.88%	14,338 $195,000
Q4 2018 Feb 07, 2019	SELL	$8.38 - $13.44 $5,396 - $8,655	-644 Reduced 4.06%	15,233 $146,000
Q3 2018 Nov 14, 2018	BUY	$11.6 - $16.54 $6,762 - $9,642	583 Added 3.81%	15,877 $192,000
Q2 2018 Aug 14, 2018	SELL	$13.13 - $17.09 $5,291 - $6,887	-403 Reduced 2.57%	15,294 $239,000
Q1 2018 May 15, 2018	BUY	$13.76 - $17.12 $2,077 - $2,585	151 Added 0.97%	15,697 $236,000
Q4 2017 Feb 14, 2018	BUY	$12.51 - $16.24 $1,013 - $1,315	81 Added 0.52%	15,546 $224,000
Q3 2017 Nov 14, 2017	BUY	$11.74 - $15.78 $181,559 - $244,037	15,465	15,465 $233,000

Others Institutions Holding FOLD

# of Institutions

319

Shares Held

320M

Call Options Held

1.09M

Put Options Held

1.04M

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.66B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC Amicus Therapeutics, Inc. Transaction History